Abstract
This research service give a detailed analysis of the European hGH market from
2007 to 2014. The effect of various drivers and challenges for the hGH market
are discussed and revenue forecasts provided based on market dynamics.
Reimbursements issues and approval processes are described. Revenue forecasts
include revenues by each country in Europe. Strategic recommendations are
provided for the various challenges facing LIMS vendors in the European market.
Table of Contents
1 EXECUTIVE SUMMARY
- Executive Summary for European hGH Market
2 GLOSSARY AND EXCHANGE RATES
- Glossary
- Exchange Rates
- 1. Exchange Rates for the Total European Human Growth Hormones Market
3 INDUSTRY CHALLENGES
- Identification of Key Industrial Challenges Facing the Total European hGH
Market
- 1. Key Industry Challenges
4 EUROPEAN HUMAN GROWTH HORMONES MARKET
- Total European Human Growth Hormones Market
- 1. Product Overview
- 2. Disease Overview
- 3. Research Methodology
- 4. Market Segmentation
- 5. Measurements
- 6. Market Drivers
- 7. Market Restraints
- 8. Revenue Forecasting Analysis
- 9. Market and Pricing Trends
- 10. Competitive Analysis
5 DEMOGRAPHIC ANALYSIS
- Geographical Trends
- 1. Overview
- 2. The United Kingdom
- 3. Germany
- 4. France
- 5. Spain
- 6. Italy
- 7. Benelux
- 8. Scandinavia
6 PIPELINE ANALYSIS
- Pipeline Review
- 1. Recent Clinical Developments
7 STRATEGIC RECOMMENDATIONS FOR THE EUROPEAN HGH MARKET
- Strategic Recommendations
- 1. Strategic Recommendations
8 DATABASE OF KEY INDUSTRY PARTICIPANTS
- Industry Participants
- 1. Key Industry Participants
9 DECISION SUPPORT DATABASE FOR EUROPEAN HGH MARKET
- Decision Support Database Tables
- 1. Total Pharmaceutical R&D Expenditures
- 2. Government Biotechnology R&D Database
- 3. Venture Capital Investment in Biotechnology R&D
- 4. Total Healthcare Expenditure
- 5. Total Number of Biotechology Companies
| 
